CHRNB3 Antikörper
Kurzübersicht für CHRNB3 Antikörper (ABIN7636899)
Target
Alle CHRNB3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Monoclonal Antibody to Cholinergic Receptor, Nicotinic, Beta 3 (CHRNb3)
-
Spezifität
- The antibody is a mouse monoclonal antibody raised against CHRNb3. It has been selected for its ability to recognize CHRNb3 in immunohistochemical staining and western blotting.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 67-218) antibody
CHRNB3 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 25-232) antibodyCHRNB3 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 7C9F12 unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 176-225) antibodyCHRNB3 Reaktivität: Human, Maus, Ratte, Hund, Meerschweinchen, Rind (Kuh), Kaninchen, Huhn, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 128-223) antibodyCHRNB3 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 3G6 unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (Internal Region) antibodyCHRNB3 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 187-200) antibodyCHRNB3 Reaktivität: Hamster WB Wirt: Kaninchen Polyclonal RB49738 unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (Internal Region) antibodyVerified CHRNB3 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (Middle Region) antibodyCHRNB3 Reaktivität: Human, Maus, Ratte, Hund, Huhn, Xenopus laevis WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.
-
Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
-
- CHRNB3 (Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3))
-
Andere Bezeichnung
- CHRNb3
-
Hintergrund
- CHR-NB3, CHRN-B3, N-AChRB3, NAChRB3, N-AChR-B3, Neuronal Acetylcholine Receptor Beta 3
-
UniProt
- Q05901
Target
-
